Effect of Platelet Rich Plasma on Outcome of Narrow Band UVB in Treatment of Vitiligo; Clinical and Histopathological Study
Conditions: Management of Stable Vitiligo Interventions: Procedure: platelet rich plasma, narrow band UVB Sponsors: Sohag University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Vitiligo Treatment by Targeting TYK2 Mediated Responses
Conditions: Vitiligo, Generalized Interventions: Drug: Deucravacitinib; Other: Volunteer without treatment Sponsors: Centre Hospitalier Universitaire de Nice Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases
Conditions: Psoriasis; Alopecia Areata; Hidradenitis Suppurativa; Vitiligo; Atopic Dermatitis Interventions: Behavioral: HautKompass Sponsors: Universit ätsklinikum Hamburg-Eppendorf; German Federal Ministry of Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo
Conditions: Alopecia Areata; Vitiligo; Atopic Dermatitis; Psoriasis Interventions: Other: Observational Sponsors: Blueskin AS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Evaluation of Pyroptosis-related Indicators in the Pathogenesis of Vitiligo:Across-sectional Comparative Study
Conditions: Vitiligo Interventions: Diagnostic Test: evaluate serum levels pyroptosis-related indicators (GASDM-D, IL 1 β& IL-18) Sponsors: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials
Evaluation of Serum and Tissue Cathepsin L in Non-segmental Vitiligo Patients
Conditions: Vitiligo Interventions: Diagnostic Test: blood sample and tissue biopsy Sponsors: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials
Vitiligo Registry for Adults and Children in the UK
Conditions: Dermatologic Disease; Vitiligo Sponsors: The Royal Wolverhampton Hospitals NHS Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
5-fluorouracil for Treatment of Stable Vitiligo
Conditions: Vitiligo Interventions: Drug: 5 fluorouracil; Other: Saline Sponsors: Al-Azhar University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
Conditions: Vitiligo Interventions: Drug: Ritlecitinib; Drug: Ritlecitinib 100 mg; Drug: Placebo Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials
A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo
Conditions: Vitiligo Interventions: Drug: Upadacitinib; Drug: Placebo Sponsors: AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)
Conditions: NonSegmental Vitiligo Interventions: Drug: Povorcitinib; Drug: Placebo Sponsors: Incyte Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)
Conditions: NonSegmental Vitiligo Interventions: Drug: Povorcitinib; Drug: Placebo Sponsors: Incyte Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)
Conditions: Non-segmental Vitiligo Interventions: Biological: MK-6194; Drug: Placebo Sponsors: Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo
Conditions: Vitiligo Interventions: Drug: Afamelanotide and NB-UVB Light; Procedure: NB-UVB Light Sponsors: Clinuvel, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 31, 2023 Category: Research Source Type: clinical trials
Investigating Healthcare Disparities in Vitiligo
Conditions: Vitiligo Interventions: Other: No intervention Sponsors: Momentum Data; Pfizer Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials
